A new curcumin analogue exhibits enhanced antitumor activity in nasopharyngeal carcinoma

Oncol Rep. 2013 Jul;30(1):239-45. doi: 10.3892/or.2013.2457. Epub 2013 May 14.

Abstract

The aim of the present study was to evaluate the antitumor effects of the curcumin analogue GL63 on radioresistant nasopharyngeal carcinoma (NPC) CNE2R cells and parental CNE2 cells. The cell viability and proliferation of NPC cells were detected by MTT assay and colony formation assay. The suppressive effect on tumor growth was examined using in vivo subcutaneously inoculated NPC tumor models using nude mice. The cell cycle distribution was detected using flow cytometry. Apoptosis was examined by Hoechst 33342 and Annexin V/PI staining assay. The protein expression of endoplasmic reticulum (ER) stress pathway markers, XBP-1, ATF-4 and CHOP, were examined by western blotting. A growth inhibitory effect was observed following treatment with GL63 in a dose-dependent manner and was more potent when compared to curcumin. GL63 at 5 µM induced significant G2/M arrest and apoptosis in NPC. The tumor-suppressive activity of GL63 in NPC xenograft models was more potent when compared to curcumin. Furthermore, GL63 induced an ER stress response, upregulation of CHOP, XBP-1 and ATF-4 expression, while the same concentration of curcumin had no effect on ER stress. These results suggest that GL63 has more potent antitumor activity than curcumin, which is associated with activation of ER stress, induction of G2/M arrest and apoptosis in NPC cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Activating Transcription Factor 4 / biosynthesis
  • Animals
  • Antineoplastic Agents / pharmacology*
  • Antineoplastic Agents / therapeutic use
  • Apoptosis / drug effects
  • Bromobenzenes / pharmacology*
  • Bromobenzenes / therapeutic use
  • Carcinoma
  • Cell Line, Tumor
  • Cell Proliferation / drug effects
  • Cell Survival / drug effects
  • Curcumin / analogs & derivatives
  • Curcumin / pharmacology*
  • Curcumin / therapeutic use
  • DNA-Binding Proteins / biosynthesis
  • Endoplasmic Reticulum Stress / drug effects
  • Female
  • G2 Phase Cell Cycle Checkpoints / drug effects
  • Humans
  • Mice
  • Mice, Nude
  • Nasopharyngeal Carcinoma
  • Nasopharyngeal Neoplasms / drug therapy*
  • Pentanones / pharmacology*
  • Pentanones / therapeutic use
  • Regulatory Factor X Transcription Factors
  • Transcription Factor CHOP / biosynthesis
  • Transcription Factors / biosynthesis
  • X-Box Binding Protein 1
  • Xenograft Model Antitumor Assays

Substances

  • 1,5-bis(2-bromophenyl)penta-1,4-dien-3-one
  • ATF4 protein, human
  • Antineoplastic Agents
  • Bromobenzenes
  • DDIT3 protein, human
  • DNA-Binding Proteins
  • Pentanones
  • Regulatory Factor X Transcription Factors
  • Transcription Factors
  • X-Box Binding Protein 1
  • XBP1 protein, human
  • Xbp1 protein, mouse
  • Activating Transcription Factor 4
  • Transcription Factor CHOP
  • Curcumin